| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/14/2011 | CA2464668C Method for the preparation of purified microparticles |
| 06/14/2011 | CA2452738C Gastric retention controlled drug delivery system |
| 06/14/2011 | CA2436421C Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 06/14/2011 | CA2425780C Composition with a base of a therapeutically active compound, in particular honey, for the treatment of wounds |
| 06/14/2011 | CA2405787C Method for preparing microparticles having a selected polymer molecular weight |
| 06/14/2011 | CA2369591C Disodium salts, monohydrate, and ethanol solvates |
| 06/14/2011 | CA2365416C Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 06/14/2011 | CA2349490C Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
| 06/14/2011 | CA2338419C Pulmonary delivery of active agents |
| 06/09/2011 | WO2011069082A2 Red blood cell-mimetic particles and methods for making and use thereof |
| 06/09/2011 | WO2011069076A2 Sustained release donepezil formulations |
| 06/09/2011 | WO2011069075A2 Treating impulse control disorders with catechol-o- methyl-transferase inhibitors |
| 06/09/2011 | WO2011068963A2 Integrated ingestible event marker system with pharmaceutical product |
| 06/09/2011 | WO2011068955A1 Ophthalmic emulsion |
| 06/09/2011 | WO2011068916A1 Pegylated polyplexes for polynucleotide delivery |
| 06/09/2011 | WO2011068872A2 Carboxyvinyl polymer-containing nanoparticle suspension |
| 06/09/2011 | WO2011068774A2 Methods for regulating gelation of hydrogel solutions and uses thereof |
| 06/09/2011 | WO2011068723A1 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 06/09/2011 | WO2011068722A1 Transdermal testosterone device and delivery |
| 06/09/2011 | WO2011068522A1 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| 06/09/2011 | WO2011068455A1 Microspheres of hydrolysed starch with endogenous, charged ligands |
| 06/09/2011 | WO2011068271A1 Method for manufacturing a silica powder coated with an antibacterial agent, and topical dermatological composition including same |
| 06/09/2011 | WO2011067791A2 Process for preparing pharmaceutical ophthalmic compositions |
| 06/09/2011 | WO2011067693A1 Compositions comprising nonsteroidal anti - inflammatory drugs |
| 06/09/2011 | WO2011067669A2 Hydrophilic filtration during manufacture of vaccine adjuvants |
| 06/09/2011 | WO2011067403A1 Starch derivative mixtures |
| 06/09/2011 | WO2011067302A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
| 06/09/2011 | WO2011066980A2 Oral dosage forms with reduced potential for drug abuse |
| 06/09/2011 | WO2011066970A2 Transdermal therapeutic system for the administration of peptides |
| 06/09/2011 | WO2011066949A1 Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non- esterified fatty acid |
| 06/09/2011 | WO2011066684A1 Liposome of irinotecan or its hydrochloride and preparation method thereof |
| 06/09/2011 | WO2011066651A1 Snalp formulations containing antioxidants |
| 06/09/2011 | WO2011038446A8 Cosmetic foam |
| 06/09/2011 | WO2011037551A3 Carrying of a combination containing tiotropium in a blister strip |
| 06/09/2011 | WO2011037549A3 Dry powder formulation of tiotropium carried in blister strip |
| 06/09/2011 | WO2011027248A4 Oral liquid formulation comprising salbutamol and guaifenesin |
| 06/09/2011 | WO2011022291A3 Photoregulated reversible hydrogels for delivery and releasing of drugs and other therapeutical reagents |
| 06/09/2011 | WO2011019954A3 Intracochlear drug delivery to the central nervous system |
| 06/09/2011 | WO2010057036A3 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
| 06/09/2011 | WO2010047826A3 Dosing regimens and dosage formulations of an antiviral peptide therapeutic |
| 06/09/2011 | US20110137289 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| 06/09/2011 | US20110136915 Rapid dissolution formulation of a calcium receptor-active compound |
| 06/09/2011 | US20110136851 Sucralose Formulations To Mask Unpleasant Tastes |
| 06/09/2011 | US20110136847 High Concentration Formulations of Opioids and Opioid Derivatives |
| 06/09/2011 | US20110136772 Sugar coatings and methods therefor |
| 06/09/2011 | US20110136744 Cyclosporin analog formulations |
| 06/09/2011 | US20110136669 Continuous Fiber Layer Comprising an Active Substance on the Basis of Bio-Polymers, the use Thereof, and Method for the Production Thereof |
| 06/09/2011 | US20110135799 Thickened beverages for dysphagia |
| 06/09/2011 | US20110135798 Microcrystalline Cellulose Compositions |
| 06/09/2011 | US20110135752 Methods For Preserving Ophthalmic Solutions and Preserved Ophthalmic Solutions |
| 06/09/2011 | US20110135744 Nanoparticle Based Therapy for Dispersing Mucin |
| 06/09/2011 | US20110135743 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 06/09/2011 | US20110135742 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| 06/09/2011 | US20110135741 Sustained-release composition and method for producing the same |
| 06/09/2011 | US20110135740 Tissue substitutes comprising stem cells and reduced ceria |
| 06/09/2011 | US20110135739 Oral Formulations of a Hedgehog Pathway Inhibitor |
| 06/09/2011 | US20110135738 Single dosage pharmaceutical formulation comprising eprosartan mesylate |
| 06/09/2011 | US20110135737 Compositions for respiratory delivery of active agents and associated methods and systems |
| 06/09/2011 | US20110135736 Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent |
| 06/09/2011 | US20110135735 Process for production of a composite material having antimicrobial activity |
| 06/09/2011 | US20110135734 Method For the Preparation of Nanoparticles From Nanoemulsions |
| 06/09/2011 | US20110135733 Aldehyde conjugated flavonoid preparations |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135731 Abuse-resistant opioid dosage form |
| 06/09/2011 | US20110135730 Oral Formulations of Glycyl-2-Methylprolyl-Glutamate |
| 06/09/2011 | US20110135729 Methods for Controlling Heat Generation of Magnetic Nanoparticles and Heat Generating Nanomaterials |
| 06/09/2011 | US20110135728 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/09/2011 | US20110135727 Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal |
| 06/09/2011 | US20110135726 Hydrogel composites and wound dressings |
| 06/09/2011 | US20110135725 Lipid Construct for Delivery of Insulin to a Mammal |
| 06/09/2011 | US20110135724 Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting |
| 06/09/2011 | US20110135723 Pharmaceutical compositions containing pregabalin |
| 06/09/2011 | US20110135722 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 06/09/2011 | US20110135721 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 06/09/2011 | US20110135720 Polymer coatings containing phytochemical agents and methods for making and using same |
| 06/09/2011 | US20110135719 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 06/09/2011 | US20110135718 Viral particle-like structure in physiological conditions, and method of forming it |
| 06/09/2011 | US20110135717 Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity |
| 06/09/2011 | US20110135716 Delivery of h2 antagonists |
| 06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
| 06/09/2011 | US20110135714 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 06/09/2011 | US20110135713 Antimicrobial and Antiviral Compounds and Methods for Their Use |
| 06/09/2011 | US20110135712 Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration |
| 06/09/2011 | US20110135711 Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors |
| 06/09/2011 | US20110135710 Methods and Compositions for the Inhibition of Gene Expression |
| 06/09/2011 | US20110135709 Adhesive skin patch |
| 06/09/2011 | US20110135708 Dietary supplement - liquid filled gum |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135706 Nerve treatment devices and methods |
| 06/09/2011 | US20110135700 In situ bulking composition |
| 06/09/2011 | US20110135699 Particles of collagen material and process for the preparation |
| 06/09/2011 | US20110135698 Multilayered blood product |
| 06/09/2011 | US20110135697 Edible holographic silk products |
| 06/09/2011 | US20110135696 Multipotent neural cells |
| 06/09/2011 | US20110135695 Oral dosage form for controlled drug release |
| 06/09/2011 | US20110135694 Partial dip coating of dosage forms for modified release |
| 06/09/2011 | US20110135693 Patch |
| 06/09/2011 | US20110135582 Combination of medicaments for the treatment of respiratory diseases |
| 06/09/2011 | US20110135581 Methods and Compositions for Reducing Lung Inflammation in an Animal |
| 06/09/2011 | US20110135580 Novel Medicament Combinations for the Treatment of Respiratory Diseases |